CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Heidi›
News
Heidi

Heidi

Heidi is a Melbourne-based AI care partner for clinical documentation and point-of-care evidence.

Melbourne, Victoria, AU🇦🇺
Founded
2019
Loading
Overview
M & A
Analysis
Compare
Fundraising
Employees
News
Library

Latest News About Heidi

More agents go rogue — but AI companies aren’t slowing down yet

SiliconAngle

More agents go rogue — but AI companies aren’t slowing down yet

It’s becoming more apparent every day that artificial intelligence agents are escaping our control — but it’s not yet apparent who or what...

Sep 25, 2026

Heidi raises $340m and doubles its valuation to $900m

The Next Web

Heidi raises $340m and doubles its valuation to $900m

Heidi raised US$340 million including a US$100 million Series C led by Blackbird valuing the company at US$900 million, plus US$240 million...

Sep 22, 2026

Heidi Launches Evidence and Acquires AutoMedica to Accelerate Its AI Care Partner Platform

Heidi Health

Heidi Launches Evidence and Acquires AutoMedica to Accelerate Its AI Care Partner Platform

Heidi announced the launch of Heidi Evidence and the acquisition of UK-based clinical AI company AutoMedica, marking its evolution from an...

Feb 24, 2026

Heidi Health raises $65M to expand global reach of its AI medical scribe platform

MobiHealthNews

Heidi Health raises $65M to expand global reach of its AI medical scribe platform

Australia-based Heidi Health closed a $65 million Series B led by Point72 Private Investments, with participation from existing investors...

Oct 6, 2025

Heidi Secures $65 Million USD in Series B Funding to Accelerate Building an AI Care Partner for Every Clinician

Heidi Health

Heidi Secures $65 Million USD in Series B Funding to Accelerate Building an AI Care Partner for Every Clinician

Heidi announced the closing of a $65 million Series B round led by Point72 Private Investments, with participation from Blackbird,...

Oct 6, 2025

GP administration startup Heidi Health tops up Series A with another $27 million

Startup Daily

GP administration startup Heidi Health tops up Series A with another $27 million

Heidi Health raised a further $26.8 million (US$16.6m) to top up its 18-month-old Series A, in a follow-on led by Headline with support...

Mar 4, 2025